Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons.
D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001551:Benz(a)Anthracenes / Q000494:pharmacology; D001580:Benzopyrenes / Q000378:metabolism; D001623:Betamethasone / Q000494:pharmacology; D002273:Carcinogens / Q000378:metabolism*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects; D005419:Flavonoids / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D005938:Glucocorticoids; D006838:Hydrocarbons / Q000378:metabolism; D007274:Injections, Intraperitoneal; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D011279:Pregnanetriol / Q000494:pharmacology; D012867:Skin / Q000201:enzymology*; D012878:Skin Neoplasms / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D001551:Benz(a)Anthracenes; D001580:Benzopyrenes; D002273:Carcinogens; D005419:Flavonoids; D005938:Glucocorticoids; D006838:Hydrocarbons; D005446:Fluocinolone Acetonide; D011279:Pregnanetriol; D008748:Methylcholanthrene; D001623:Betamethasone; D006899:Mixed Function Oxygenases; D004121:Dimethyl Sulfoxide